Showing results (91-100 of 244) with videos related to

Sort By:
Pageof 25
Drug Discovery Today|May 18, 2016
Microfluidic models for adoptive cell-mediated cancer immunotherapiesGiulia Adriani, Andrea Pavesi, Anthony T Tan, et al.
Tuberculosis (Edinburgh, Scotland)|May 22, 2003
Human immunity to M. tuberculosis: T cell subsets and antigen processingW H Boom, David H Canaday, Scott A Fulton, et al.
Science Translational Medicine|July 2, 2025
Targeting HBV with RNA interference: Paths to cureMatteo Iannacone, Cristian G Beccaria, Lena Allweiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patientsAkeel Alisa, Annette Ives, Ansar A Pathan, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2018
CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8+ T cells to Tc1 phenotypeBhushan Dharmadhikari, Emily Nickles, Zulkarnain Harfuddin, et al.
The Journal of Clinical Investigation|July 25, 2017
Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infectionJanine Kah, Sarene Koh, Tassilo Volz, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2021
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responsesDelia Goletti, Linda Petrone, Davide Manissero, et al.
Hepatology (Baltimore, Md.)|November 7, 2021
Immunomodulation and RNA interference alter hepatitis B virus-specific CD8 T-cell recognition of infected HepG2-NTCPAdrian Kuipery, Juan Diego Sanchez Vasquez, Aman Mehrotra, et al.
Gastroenterology|April 6, 2012
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cellsElena Sandalova, Diletta Laccabue, Carolina Boni, et al.
Pageof 25